The research collaboration for a monovalent vaccine targeting the Zaire strain of the Ebola virus is part of an ongoing development program for a multivalent vaccine
against all virus strains that cause disease in humans, including Ebola and Marburg viruses based on the Ad26 and Ad35 vectors.
But this is a significant first step in the design of a multivalent vaccine
against several autism-related gut bacteria," he said.
The results of this study indicate that the NDV (B1) and IBV (ARK) vaccines and a multivalent vaccine
constituted by NDV (B1) and IBV (ARK and MASS) did not interfere with the protection induced by the CEO ILTV vaccine.
Earlier studies from north India showed high diversity of emm types encountered in a single year, but no specific emm type could be associated with the isolation site and those studies stressed upon the selection of emm types for vaccine development and/or need to tailor multivalent vaccine
for regional use (7,10).
Bavarian Nordic's proprietary and patented technology MVA-BN is one of the world's safest, multivalent vaccine
Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine
This multivalent vaccine
also has the advantage of being incapable of generating infectious HIV-1 virus because of the segregation of the HIV genome into 32 separate plasmids.
A multidose, multivalent vaccine
containing formalin-inactivated EEEV and WEEV, influenza virus, and tetanus toxoid was administered to the affected horse and 27 stable mates 1 week before the onset of illness.
The group B strep vaccine study, based at Baylor College of Medicine, Houston, is merely the first step in the planned development of a multivalent vaccine
that will probably need to contain at least five different capsular types in order to prevent the prevalent group B strep strains, added Dr.
The idea of making a multivalent vaccine
is not foreign," Gerety says, but "viruses that have the ability to change in unpredictable ways like this one [can] make it very difficult.
The company's lead product is a multivalent vaccine
against group A streptococcus using recombinant DNA technology to produce purified proteins as subunit or "non-live" vaccines.
We are pleased that we have been able to show that a multivalent vaccine
for both anthrax and ricin is feasible.